Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 2

Status

Completed 5Terminated 2

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1Sarcoma 1Head & Neck 1Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Oligodendroglioma 1Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Interventional × terameprocol × Clear all
NCT02575794 2023-10-06

Terameprocol in Treating Patients With Recurrent High Grade Glioma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
20 enrolled
CNS

Glioma

NCT00404248 2019-03-06

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
35 enrolled 13 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00057512 2016-02-23

Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck

Erimos Pharmaceuticals

Phase 1 Completed
9 enrolled
Head & Neck

Head and Neck Neoplasms

NCT00154089 2016-02-23

A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia

Erimos Pharmaceuticals

Phase 1/2 Completed
8 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00259818 2008-01-24

Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors

Erimos Pharmaceuticals

Phase 1 Completed
30 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡